Jörg Haupenthal

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

Archiv der Pharmazie

ACS infectious diseases

RSC medicinal chemistry

Chemical science

Helmholtz-Institut für Pharmazeutische Forschung Saarland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz-Institut für Pharmazeutische Forschung Saarland Aug 01 2009

Germany

Researcher :: Drug Design and Optimization

Publications

Jörg Haupenthal, Muhammad Rafehi, Andreas Martin Kany, Anne Lespine, Katja Stefan, Anna Katharina Herta Hirsch, Sven Marcel Stefan
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs). Archiv der Pharmazie 357 (9) (2024)
Hend Khalifa, Sari Rasheed, Jörg Haupenthal, Jennifer Herrmann, Yasmine M Mandour, Ashraf H Abadi, Matthias Engel, Rolf Müller, Anna K H Hirsch, Mohammad Abdel-Halim, Mostafa M Hamed
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agents. Archiv der Pharmazie (2024)
Olga Metelkina, Jelena Konstantinović, Andreas Klein, Roya Shafiei, Mario Fares, Alaa Alhayek, Samir Yahiaoui, Walid A M Elgaher, Jörg Haupenthal, Alexander Titz, Anna Katharina Herta Hirsch
Dual inhibitors of Pseudomonas aeruginosa virulence factors LecA and LasB. Chemical science 15 (33) (2024)
Hend Khalifa, Sari Rasheed, Jörg Haupenthal, Jennifer Herrmann, Yasmine M Mandour, Ashraf H Abadi, Matthias Engel, Rolf Müller, Anna K H Hirsch, Mohammad Abdel-Halim, Mostafa M Hamed
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agents. Archiv der Pharmazie 357 (4) (2024)
Hend Khalifa, Sari Rasheed, Jörg Haupenthal, Jennifer Herrmann, Yasmine M Mandour, Ashraf H Abadi, Matthias Engel, Rolf Müller, Anna K H Hirsch, Mohammad Abdel-Halim, Mostafa M Hamed
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agents. Archiv der Pharmazie 357 (4) (2024)
Jörg Haupenthal, Muhammad Rafehi, Andreas Martin Kany, Anne Lespine, Katja Stefan, Anna Katharina Herta Hirsch, Sven Marcel Stefan
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs). Archiv der Pharmazie (2024)
Hend Khalifa, Sari Rasheed, Jörg Haupenthal, Jennifer Herrmann, Yasmine M Mandour, Ashraf H Abadi, Matthias Engel, Rolf Müller, Anna K H Hirsch, Mohammad Abdel-Halim, Mostafa M Hamed
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agents. Archiv der Pharmazie 357 (4) (2024)
Olga Metelkina, Jelena Konstantinović, Andreas Klein, Roya Shafiei, Mario Fares, Alaa Alhayek, Samir Yahiaoui, Walid A M Elgaher, Jörg Haupenthal, Alexander Titz, Anna Katharina Herta Hirsch
Dual inhibitors of Pseudomonas aeruginosa virulence factors LecA and LasB. Chemical science 15 (33) (2024)
Virgyl Camberlein, Gwenaëlle Jézéquel, Jörg Haupenthal, Anna Katharina Herta Hirsch
The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB. Antibiotics (Basel, Switzerland) 11 (8) (2022)
Henni-Karoliina Ropponen, Eleonora Diamanti, Alexandra Siemens, Boris Illarionov, Jörg Haupenthal, Markus Fischer, Matthias Rottmann, Matthias Witschel, Anna Katharina Herta Hirsch
Assessment of the rules related to gaining activity against Gram-negative bacteria. RSC medicinal chemistry 12 (4) (2021)
Katrin Voos, Esther Schönauer, Alaa Alhayek, Jörg Haupenthal, Anastasia Andreas, Daniel Krug, Rolf Wolfgang Hartmann, Katharina Häussermann, Anna Katharina Herta Hirsch, Christian Ducho
Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH). ChemMedChem 16 (8) (2021)
Samir Yahiaoui, Katrin Voos, Jörg Haupenthal, Thomas A Wichelhaus, Denia Frank, Lilia Weizel, Marco Rotter, Steffen Brunst, Jan S Kramer, Ewgenij Proschak, Christian Ducho, Anna Katharina Herta Hirsch
N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa. RSC medicinal chemistry 12 (10) (2021)
Jörg Haupenthal, Yannik Kautz, Walid A M Elgaher, Linda Pätzold, Teresa Röhrig, Matthias W Laschke, Thomas Tschernig, Anna Katharina Herta Hirsch, Vadim Molodtsov, Katsuhiko S Murakami, Rolf Wolfgang Hartmann, Markus Bischoff
Evaluation of Bacterial RNA Polymerase Inhibitors in a Staphylococcus aureus-Based Wound Infection Model in SKH1 Mice. ACS infectious diseases 6 (10) (2020)
Andreas Martin Kany, Asfandyar Sikandar, Samir Yahiaoui, Jörg Haupenthal, Isabell Walter, Martin Empting, Jesko Koehnke, Rolf Wolfgang Hartmann
Tackling Pseudomonas aeruginosa Virulence by a Hydroxamic Acid-Based LasB Inhibitor. ACS chemical biology 13 (9) (2018)
Andreas Martin Kany, Asfandyar Sikandar, Jörg Haupenthal, Samir Yahiaoui, Christine K Maurer, Ewgenij Proschak, Jesko Koehnke, Rolf Wolfgang Hartmann
Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa. ACS infectious diseases 4 (6) (2018)
Florian Graef, Robert Richter, Verena Fetz, Xabier Murgia, Chiara De Rossi, Nicole Schneider-Daum, Giuseppe Allegretta, Walid Elgaher, Jörg Haupenthal, Martin Empting, Felix Beckmann, Mark Brönstrup, Rolf Wolfgang Hartmann, Sarah Gordon, Claus-Michael Lehr
In Vitro Model of the Gram-Negative Bacterial Cell Envelope for Investigation of Anti-Infective Permeation Kinetics. ACS infectious diseases 4 (8) (2018)
Esther Schönauer, Andreas Martin Kany, Jörg Haupenthal, Kristina Hüsecken, Isabel J Hoppe, Katrin Voos, Samir Yahiaoui, Brigitta Elsässer, Christian Ducho, Katharina Häussermann, Rolf Wolfgang Hartmann
Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases. Journal of the American Chemical Society 139 (36) (2017)

Jörg Haupenthal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jörg Haupenthal